MRVI

Maravai Lifesciences Holdings, Inc.

A maker of the raw ingredients behind mRNA vaccines and therapies, Maravai LifeSciences supplies everything from its CleanCap® capping technology to impurity-detection kits used by biopharma and diagnostics companies in roughly sixty countries through its TriLink and Cygnus brands. Formed in 2014 by Carl Hull, Eric Tardif, and the private-equity firm GTCR, it grew by buying scientifically driven companies like TriLink and Cygnus. Its CleanCap® technology was a key ingredient in the Pfizer-BioNTech COVID-19 vaccine, and its name is the northern Italian word for "miracle."

Recent Activity

Show $

2026Q2

2 buys

ArrowMark PartnersNEW

+1.27M shares

ArrowMark PartnersNEW

+1.27M shares

First Eagle Investment ManagementADD

+1.15M shares(+45.4%)

First Eagle Investment ManagementADD

+1.15M shares(+45.4%)

2026Q1

1 buy

First Eagle Investment ManagementADD

+725.0K shares(+40.3%)

First Eagle Investment ManagementADD

+725.0K shares(+40.3%)

Loading more activity...